A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

January 11, 2021

Primary Completion Date

October 26, 2026

Study Completion Date

October 26, 2026

Conditions
Prurigo Nodularis
Interventions
DRUG

Nemolizumab

Nemolizumab 30 mg will be administered as subcutaneous (SC) injection.

Trial Locations (164)

1011

Galderma Investigational Site, Lausanne

1090

Galderma Investigational Site, Jette

1200

Galderma Investigational Site, Brussels

1220

Galderma Investigational Site, Vienna

2900

Galderma Investigational Site, Hellerup

3000

Galderma Investigational Site, Leuven

3010

Galderma Investigational Site, Bern

3508

Galderma Investigational Site, Utrecht

4000

Galderma Investigational Site, Liège

4020

Galderma Investigational Site, Linz

5000

Galderma Investigational Site, Szolnok

6000

Galderma Investigational Site, Kecskemét

6363

Galderma Investigational Site, Obbürgen

6374

Galderma Investigational Site, Buochs

6720

Galderma Investigational Site, Szeged

8036

Galderma Investigational Site, Graz

8200

Galderma Investigational Site, Aarhus

8570

Galderma Investigational Site, Weinfelden

9000

Galderma Investigational Site, Ghent

9007

Galderma Investigational Site, Sankt Gallen

9700

Galderma Investigational Site, Groningen

10021

Galderma Investigational Site, New York

10065

Galderma Investigational Galderma Investigational Site, New York

10117

Galderme Investigational Site, Berlin

15355

Galderma Investigational Site, Gyeonggi-do

16132

Galderma Investigational Site, Genova

17176

Galderma Investigational Site, Solna

19103

Galderma Investigational Site, Philadelphia

20037

Galderma Investigational Site, Washington D.C.

20246

Galderma Investigational Site, Eppendorf

20251

Galderma Investigational Site, Hamburg

21231

Galderma Investigational Site, Baltimore

22031

Galderma Investigational Site, Fairfax

23538

Galderma Investigational Site, Lübeck

24105

Galderma Investigational Site, Kiel

24501

Galderma Investigational Site, Lynchburg

26505

Galderma Investigational Site, Morgantown

26953

Galderma Investigational Site, Valence

27104

Galderma Investigational Site, Winston-Salem

27262

Galderma Investigational Site, High Point

27617

Galderma Investigational Site, Raleigh

29200

Galderma Investigational Site, Brest

29621

Galderma Investigational Site, Anderson

30263

Galderma Investigational Site, Newnan

31000

Galderma Investigational Site, Toulouse

31217

Galderma Investigational Site, Macon

31904

Galderma Investigational Galderma Investigational Site, Columbus

32174

Galderma Investigational Site, Ormond Beach

33000

Galderma Investigational Site, Bordeaux

33021

Galderma Investigational Site, Hollywood

33028

Galderma Investigational Site, Pembroke Pines

33125

Galderma Investigational Site, Miami

33136

Galderma Investigational Site, Miami

33162

Galderma Investigational Site, North Miami Beach

33180

Galderma Investigational Site, Aventura

33484

Galderma Investigational Site, Delray Beach

33607

Galderma Investigational Site, Tampa

33770

Galderma Investigational Site, Largo

35019

Galderma Investigational Site, Las Palmas de Gran Canaria

35233

Galderma Investigational Site, Birmingham

35244

Galderma Investigational Site, Birmingham

36100

Galderma Investigational Site, Vicenza

37075

Galderma Investigational Site, Göttingen

37130

Galderma Investigational Site, Murfreesboro

37909

Galderma Investigational Site, Knoxville

40225

Galderma Investigational Site, Düsseldorf

40241

Galderma Investigational Site, Louisville

41124

Galderma Investigational Site, Modena

42055

Galderma Investigational Site, Saint-Etienne

43016

Galderma Investigational Site, Dublin

43126

Galderma Investigational Site, Parma

44093

Galderma Investigational Site, Nantes

44106

Galderma Investigational Site, Cleveland

45627

Galderma Investigational Site, Cincinnati

46250

Galderma Investigational Site, Indianapolis

48109

Galderma Investigational Site, Ann Arbor

48149

Galderma Investigational Site, Münster

48455

Galderma Investigational Site, Bad Bentheim

49085

Galderma Investigational Site, Saint Joseph

52074

Galderma Investigational Site, Aachen

53105

Galderma Investigational Site, Bonn

55131

Galderma Investigational Site, Mainz

60044

Galderma I Galderma Investigational Site, Lake Bluff

60602

Galderma Investigational Site, Chicago

60613

Galderma Investigational Galderma Investigational Site, Chicago

63110

Galderma Investigational Site, St Louis

64297

Galderma Investigational Site, Darmstadt

64506

Galderma Investigational Site, Saint Joseph

66100

Galderma Investigational Site, Chieti

66614

Galderma Investigational Site, Topeka

67100

Galderma Investigational Site, L’Aquila

69115

Galderma Investigational Site, Heidelberg

69495

Galderma Investigational Site, Pierre-Bénite

72076

Galderma Investigational Site, Tübingen

75020

Galderma Investigational Site, Paris

75230

Galderma Investigational Site, Dallas

75475

Galderma Investigational Site, Paris

76000

Galderma Investigational Site, Rouen

77004

Galderma Investigational Site, Webster

77401

Galderma Investigational Site, Houston

78620

Galderma Investigational Site, Dripping Springs

78660

Galderma Investigational Site, Pflugerville

78738

Galderma Investigational Galderma Investigational Site, Austin

80131

Galderma Investigational Site, Napoli

80337

Galderma Investigational Site, Münich

80802

Galderma Investigational Site, Münich

84117

Galderma Investigational Site, Salt Lake City

84663

Galderma Investigational Galderma Investigational Site, Springville

86179

Galderma Investigational Site, Augsburg

89052

Galderma Investigational Site, Henderson

90045

Galderma Investigational Site, Los Angeles

92123

Galderma Investigational Site, San Diego

92130

Galderma Investigational Site, San Diego

92708

Galderma Investigational Site, Fountain Valley

94404

Galderma Investigational Site, Santa Monica

95123

Galderma Investigational Site, Catania

02111

Galderma Investigational Site, Boston

T3E OB2

Galderma Investigational Site, Calgary

N6A 3H7

Galderma Investigational Site, London

M2M 4J5

Galderma Investigational Site, North York

S7K OH6

Galderma Investigational Site, Saskatoon

T2G 1B1

Galderma Investigational Site, Calgary

N6H 5L5

Galderma Investigational Site, London

L3P 1X2

Galderma Investigational Site, Markham

M3H 5Y8

Galderma Investigational Site, Toronto

06202

Galderma Investigational Site, Nice

01307

Galderma Investigational Site, Dresden

06120

Galderma Investigational Site, Halle

06129

Galderma Investigational Site, Perugia

00144

Galderma Investigational Site, Roma

00168

Galderma Investigational Site, Roma

85-065

Galderma Investigational Site, Bydgoszcz

41-500

Galderma Investigational Site, Chorzów

42-202

Galderma Investigational Site, Częstochowa

80-382

Galderma Investigational Site, Gdansk

81-537

Galderma Investigational Site, Gdynia

40-040

Galderma Investigational Site, Katowice

31-559

Galderma Investigational Site, Krakow

90-127

Galderma Investigational Site, Lodz

90-265

Galderma Investigational Site, Lodz

90-436

Galderma Investigational Site, Lodz

20-081

Galderma Investigational Site, Lublin

10-900

Galderma Investigational Site, Olsztyn

27-400

Galderma Investigational Site, Ostrowiec Świętokrzyski

60-702

Galderma Investigational Site, Poznan

35-055

Galderma Investigational Site, Rzeszów

71-434

Galderma Investigational Site, Szczecin

01-192

Galderma Investigational Site, Warsaw

01-518

Galderma Investigational Site, Warsaw

01-817

Galderma Investigational Site, Warsaw

02-507

Galderma Investigational Site, Warsaw

02-758

Galderma Investigational Site, Warsaw

50-381

Galderma Investigational Site, Wroclaw

50-566

Galderma Investigational Site, Wroclaw

51-318

Galderma Investigational Site, Wroclaw

02841

Galderma Investigational Site, Seoul

03722

Galderma Investigational Site, Seoul

04763

Galderma Investigational Site, Seoul

07441

Galderma Investigational Site, Seoul

08041

Galderma Investigational Site, Barcelona

DY1 2HQ

Galderma Investigational Site, Dudley

G3 8SJ

Galderma Investigational Site, Glasgow

SE1 9RT

Galderma Investigational Site, London

NE1 4LP

Galderma Investigational Site, Newcastle upon Tyne

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT04204616 - A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) | Biotech Hunter | Biotech Hunter